Other languages AstraZeneca PLC Xetra

Equities

ZEG

GB0009895292

Real-time Estimate Tradegate Other stock markets 04:12:44 17/06/2024 pm IST			5-day change	1st Jan Change
147.5 ^EUR	-0.82%		-1.37%	+20.72%

10:48am	AstraZeneca: positive phase 3 results in lymphoma	CF
10:31am	AstraZeneca's Blood Cancer Combination Therapy Meets Primary Goal in Late-Stage Study	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AstraZeneca : résultats positifs de phase 3 dans le lymphome	02:18pm
AstraZeneca's Blood Cancer Combination Therapy Meets Primary Goal in Late-Stage Study	02:01pm
Astra's Imfinzi plus chemo approved for cancer form in US	01:40pm
AstraZeneca : Imfinzi approuvé dans le cancer de l'endomètre	01:08pm
La Bourse de Paris en PLS	12:33pm
Astra gets US drug approval; Ascential trades in line	12:20pm
En Direct des Marchés : Thales, Alstom, Vallourec, Casino, Sampo, Adidas, Essity, Meta, Autodesk...	12:14pm
AstraZeneca Gains US FDA Approval for Endometrial Cancer Treatment	12:05pm
UK Stocks-Factors to watch on June 17	12:00pm
AstraZeneca gets positive cancer test results for Calquence	11:54am
AstraZeneca's Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer	11:52am
AstraZeneca's Calquence Combo Extends Progression-free Survival in Mantle Cell Lymphoma Study	11:10am
AstraZeneca Announces CALQUENCE (Acalabrutinib) Plus Chemoimmunotherapy Reduced the Risk of Disease Progression or Death by 27% Vs. Standard of Care in Patients with Untreated Mantle Cell Lymphoma in Echo Phase III Trial	16/06
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	14/06
Tailandia prevé compromisos de inversión por al menos 22.000 millones de dólares en 2024	14/06
Musk se acerca al premio de 56.000 millones de dólares y al traslado de la sede de Tesla a Texas	13/06
Musk se rapproche du pactole de 56 Mds$ et du transfert du siège de Tesla au Texas	13/06
Batallas por la remuneración de los altos ejecutivos en todo el mundo	13/06
AstraZeneca : Farxiga approuvé contre le diabète dès 10 ans	13/06
AstraZeneca's Type-2 Diabetes Drug Wins Pediatric Approval in US	13/06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 09:32 pm IST